RAPPOSELLI, ILARIO GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 244
EU - Europa 195
AS - Asia 134
AF - Africa 13
SA - Sud America 4
Totale 590
Nazione #
US - Stati Uniti d'America 242
IT - Italia 71
SG - Singapore 59
CN - Cina 44
DE - Germania 23
SE - Svezia 23
IE - Irlanda 21
CH - Svizzera 16
IN - India 14
ID - Indonesia 9
CI - Costa d'Avorio 8
FI - Finlandia 8
GB - Regno Unito 8
BG - Bulgaria 7
RU - Federazione Russa 6
JO - Giordania 5
BR - Brasile 4
FR - Francia 3
HK - Hong Kong 3
NL - Olanda 3
TG - Togo 3
AT - Austria 2
CA - Canada 2
NG - Nigeria 2
BE - Belgio 1
CZ - Repubblica Ceca 1
HR - Croazia 1
UA - Ucraina 1
Totale 590
Città #
Singapore 51
Santa Clara 38
Chandler 22
Dublin 21
Fairfield 17
Bern 16
Boardman 13
Bologna 12
Turin 12
Ashburn 11
Princeton 11
New York 10
Jakarta 9
Abidjan 8
Helsinki 7
Sofia 7
Southend 7
Florence 6
Amman 5
Houston 5
Rome 5
San Diego 5
Seattle 5
Cambridge 4
Nuremberg 4
Woodbridge 4
Berlin 3
Falkenstein 3
Forlì 3
Hong Kong 3
Lomé 3
Shanghai 3
Abeokuta 2
Amsterdam 2
Beijing 2
Belo Horizonte 2
Casalecchio Di Reno 2
Cesena 2
Los Angeles 2
Monzuno 2
Mountain View 2
Mülheim 2
Ottawa 2
Parma 2
Perugia 2
Pianella 2
Ravenna 2
Romainville 2
Salerno 2
Wilmington 2
Brno 1
Brussels 1
Bühl 1
Catania 1
Cedar Knolls 1
Council Bluffs 1
Des Moines 1
Gaomi 1
Genoa 1
Guangzhou 1
Hangzhou 1
Hounslow 1
Hyderabad 1
Kiev 1
Lappeenranta 1
Lianyun 1
Milan 1
Modena 1
Monmouth Junction 1
Nanjing 1
Nantong 1
Norwalk 1
Olalla 1
Qingdao 1
Shenzhen 1
Tappahannock 1
Vienna 1
Wuhan 1
Wuxi 1
Xingtai 1
Totale 399
Nome #
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 92
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 65
Multimodal treatment with gemox plus helical tomotherapy in unresectable locally advanced pancreatic cancer: A pooled analysis of two phase 2 studies 61
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 60
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma 55
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value 48
Neoadjuvant treatment (FOLFOX4 plus hypofractionated tomotherapy) for patients with locally advanced rectal cancer: a multicenter phase II trial 44
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 43
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 43
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 41
Equivalent efficacy but different safety profiles of gemcitabine plus nab-paclitaxel and folfirinox in metastatic pancreatic cancer 41
Identification of palliative care needs and prognostic factors of survival in tailoring appropriate interventions in advanced oncological, renal and pulmonary diseases: A prospective observational protocol 30
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape: Bertinoro Workshop, November 2022 6
Totale 629
Categoria #
all - tutte 3.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 4 0 0 6 4 1
2021/202295 3 4 1 1 3 1 1 22 10 3 34 12
2022/2023173 10 16 8 6 8 8 4 14 35 12 21 31
2023/2024111 5 11 9 17 9 20 3 11 7 6 3 10
2024/2025235 22 37 37 38 47 27 27 0 0 0 0 0
Totale 629